Isabl
4 known investors
Isabl analyzes complete tumor genomes and transcriptomes to identify cancer-associated mutations and biomarkers for comprehensive cancer diagnosis. The company provides genomic testing services for oncology patients and operates in the precision medicine and cancer diagnostics sector.